ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 165 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2017. The put-call ratio across all filers is 1.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,055,000 | +5.1% | 61,500 | 0.0% | 0.45% | -13.7% |
| Q2 2020 | $4,811,000 | +58.0% | 61,500 | -10.3% | 0.52% | +21.8% |
| Q1 2020 | $3,045,000 | -30.9% | 68,524 | -27.9% | 0.43% | -28.2% |
| Q4 2017 | $4,406,000 | -17.3% | 95,000 | -5.0% | 0.60% | -12.5% |
| Q3 2017 | $5,326,000 | +141.1% | 100,000 | +181.1% | 0.68% | +114.5% |
| Q2 2017 | $2,209,000 | +351.7% | 35,573 | +255.7% | 0.32% | +264.4% |
| Q2 2016 | $489,000 | -80.7% | 10,000 | -75.0% | 0.09% | -82.7% |
| Q1 2016 | $2,532,000 | – | 40,000 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 217,459 | $24,760,000 | 1.64% |
| Motley Fool Asset Management LLC | 152,326 | $17,344,000 | 1.25% |
| Rock Springs Capital Management LP | 450,000 | $51,237,000 | 1.12% |
| AtonRa Partners | 21,017 | $2,393,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 112,200 | $12,775,000 | 0.97% |
| EMERALD ADVISERS, LLC | 228,368 | $26,002,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 239,023 | $27,215,000 | 0.90% |
| FEDERATED HERMES, INC. | 3,912,408 | $445,467,000 | 0.86% |
| HealthCor Management, L.P. | 207,610 | $23,638,000 | 0.84% |
| Atika Capital Management LLC | 66,000 | $7,515,000 | 0.65% |